These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6437705)

  • 1. Gonadotrophin responses to GnRH in precocious puberty treated with GnRH analogue.
    Donaldson MD; Stanhope R; Lee TJ; Price DA; Brook CG; Savage DC
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):499-503. PubMed ID: 6437705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible inhibition of central precocious puberty with a long acting GnRH analogue.
    Ward PS; Ward I; McNinch AW; Savage DC
    Arch Dis Child; 1985 Sep; 60(9):872-4. PubMed ID: 3931565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of GnRH analogue (Buserelin) treatment in girls with central precocious puberty.
    Brauner R; Thibaud E; Bischof P; Sizonenko PC; Rappaport R
    Acta Paediatr Scand; 1985 Nov; 74(6):945-9. PubMed ID: 3937430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).
    Stanhope R; Adams J; Brook CG
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):795-806. PubMed ID: 3926352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thelarche variant: a new syndrome of precocious sexual maturation?
    Stanhope R; Brook CC
    Acta Endocrinol (Copenh); 1990 Nov; 123(5):481-6. PubMed ID: 2124026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
    Warren MP; Mathews JH; Morishima A; Vande Wiele R
    Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin).
    Bourguignon JP; Van Vliet G; Vandeweghe M; Malvaux P; Vanderschueren-Lodeweyckx M; Craen M; Du Caju MV; Ernould C
    Eur J Pediatr; 1987 Nov; 146(6):555-60. PubMed ID: 3123239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteinizing hormone-releasing hormone analogue (Buserelin) treatment for central precocious puberty: a multi-centre trial.
    Werther GA; Warne GL; Ennis G; Gold H; Silink M; Cowell CT; Quigley C; Howard N; Antony G; Byrne GC
    J Paediatr Child Health; 1990 Feb; 26(1):4-8. PubMed ID: 2109996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring the treatment of precocious puberty with a GnRH-analog (buserelin): comparison of the GnRH-test with nocturnal pulsatility of LH, testosterone and 17-beta-estradiol].
    Radetti G; Pasquino B; Castellan C; Gentili L; Mengarda G
    Pediatr Med Chir; 1991; 13(5):471-4. PubMed ID: 1788106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue.
    Stanhope R; Pringle PJ; Brook CG
    Acta Paediatr Scand; 1988 Jul; 77(4):525-30. PubMed ID: 3293348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.
    Trueman JA; Tillmann V; Cusick CF; Foster P; Patel L; Hall CM; Price DA; Clayton PE
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):223-30. PubMed ID: 12153601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group.
    Sippell WG
    Horm Res; 1994; 41 Suppl 2():14-5. PubMed ID: 8088698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of puberty in girls with short-acting intranasal versus subcutaneous depot GnRH agonist.
    Tuvemo T; Gustafsson J; Proos LA;
    Horm Res; 2002; 57(1-2):27-31. PubMed ID: 12006716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LH-RH agonistic analog (buserelin) treatment of precocious puberty: collaborative study in Japan.
    Suwa S; Hibi I; Kato K; Nakazima H
    Acta Paediatr Jpn; 1988; 30 Suppl():176-84. PubMed ID: 3146872
    [No Abstract]   [Full Text] [Related]  

  • 16. Final height in sexually precocious girls after therapy with an intranasal analogue of gonadotrophin-releasing hormone (buserelin).
    Stasiowska B; Vannelli S; Benso L
    Horm Res; 1994; 42(3):81-5. PubMed ID: 7995616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate.
    Reiter EO; Kaplan SL; Conte FA; Grumbach MM
    Pediatr Res; 1975 Feb; 9(2):111-6. PubMed ID: 1090891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous gonadotrophin pulsatility and ovarian morphology in girls with central precocious puberty treated with cyproterone acetate.
    Stanhope R; Pringle PJ; Adams J; Jeffcoate SL; Brook CG
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):547-53. PubMed ID: 2935331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone.
    Luder AS; Holland FJ; Costigan DC; Jenner MR; Wielgosz G; Fazekas AT
    J Clin Endocrinol Metab; 1984 Jun; 58(6):966-72. PubMed ID: 6427266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up and final height in girls with central precocious puberty treated with luteinizing hormone-releasing hormone analogue nasal spray.
    Cacciari E; Cassio A; Balsamo A; Colli C; Cicognani A; Pirazzoli P; Tani G; Brondelli L; Mandini M; Bovicelli L
    Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1194-9. PubMed ID: 7921123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.